NCT03769662View on ClinicalTrials.gov

Follow on Extension of XT-150-1-0201

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 20, 2019

Primary Completion Date

October 30, 2019

Study Completion Date

December 30, 2019

Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL

XT-150

IL-10 transgene DNA plasmid injected into the knee synovial capsule

Trial Locations (1)

5005

CMAX Clinical Research Pty Ltd in collaboration with University of Adelaide, Adelaide

All Listed Sponsors
lead

Xalud Therapeutics, Inc.

INDUSTRY

NCT03769662 - Follow on Extension of XT-150-1-0201 | Biotech Hunter | Biotech Hunter